Diabetes in Cardiovascular Disease: a Companion to Braunwald's Heart Disease: Expert Consult - Online and Print

Front Cover; Inside Front Cover; Diabetes Incardiovascular Disease: A Companion To Braunwald's Heart Disease; Copyright; Dedication; Contributors; Foreword; Preface; Acknowledgments; Contents; Part I: Diabetes Mellitus; Chapter 1: Definition And Epidemiology Of Type 2 Diabetes Mellitus; Type 2 Diabetes-definitions And Outcomes; Global Burden Of Diabetes; Causal Underpinnings Of Diabetes; Genes, Epigenetics, And Gene-environment Interactions; Overweight And Obesity And Associated Lifestyle Behaviors; Other Risk Factors For Diabetes; The Future Of Diabetes Research; Summary; References Chapter 2: Insulin Resistancegenetic Factors; Insulin Resistance; Insulin Signaling And Cellular Mechanisms Of Insulin Resistance; The Insulin Receptor, Insulin Receptor Substrates, And Pkb/akt Proteins; Glucose Transport; The Role Of The Adipocyte And Obesity In Type 2 Diabetes; Tissue- And Organ-specific Contribution To Insulin Resistance; Muscle; Adipose Tissue; Liver; Brain; Beta Cell Dysfunction In Type 2 Diabetes; The Role Of Insulin Secretion And The Beta Cell In Type 2 Diabetes; Pulsatility; Glucose-dependent Insulin Secretion; Proinsulin-to-insulin Ratio Incretin Hormones And Type 2 Diabetesbeta Cell Mass; Glucose Toxicity; Lipotoxicity; Summary; References; Chapter 3: Type 1 Diabetes; Pathogenesis; Autoimmunity; Loss Of Tolerance; Autoantigens; Insulin; Glutamic Acid Decarboxylase; Insulinoma-associated Protein 2; Znt8; Islet-specific Glucose-6-phosphatase Catalytic Subunit-related Protein; Chromogranin A; Adaptive Immune Response; T Cell Response; Cytokines; Antibody Response; Innate Immune System Response; Etiology; Genetics; Hla Genes; Non-hla Genes; Insulin Gene; Cytotoxic T Lymphocyte-associated Protein 4 Gene Protein Tyrosine Phosphatase Nonreceptor Type 22 Geneinterferon Induced With Helicase C Domain 1 Gene; Interleukin 2 Receptor Alpha Subunit Gene; Epigenetics; Environmental Factors; Dietary Factors; Infectious Factors; Other Environmental Factors; Summary; References; Chapter 4: The Metabolic Syndrome; Association Between Metabolic Syndrome And Cardiovascular Disease In The Population; Associations Between Metabolic Syndrome And Intermediate Markers Of Cardiovascular Disease; Cardiovascular Diseases And Metabolic Syndrome In Patients With Abnormal Glucose Tolerance Common Soil For Metabolic Syndrome And Cardiovascular Disease?metabolic Syndrome As Guide For Patient-centered Treatment; References; Chapter 5: Lifestyle Interventions For The Prevention Of Type 2 Diabetes Mellitus; The Global Epidemic Of Type 2 Diabetes: An Overview; Evidence For Sustainable Type 2 Diabetes Prevention; The Elements Of Type 2 Diabetes Prevention; Identifying People At Risk; Physical Activity; Nutritional Aspects; Nutritional Recommendations; The Right Intervention For The Person At Risk; Supporting Behavior Change; Recommendations For Type 2 Diabetes Prevention Practice Contents Of The Type 2 Diabetes Prevention Toolkit [edited By] Darren K. Mcguire, Nikolaus Marx. Description Based Upon Print Version Of Record. Complemented By: Braunwald's Heart Disease / Edited By Robert O. Bonow [and Others]. 9th Edition 2012. Includes Bibliographical References. English

Diabetes in Cardiovascular Disease is a current, expert resource focusing on the complex challenges of providing cardiovascular care to patients with diabetes. Designed as a companion to Braunwald’s Heart Disease, this interdisciplinary medical reference book bridges the gap between the cardiology and endocrinology communities of scientists and care providers, and highlights the emerging scientific and clinical topics that are relevant for cardiologists, diabetologists/endocrinologists, and the extended diabetes care team.

• Access essential coverage of basic and clinical sciences, complemented by an expanded focus on epidemiology, behavioral sciences, health policy, and disparities in health care.
• Take advantage of a format that follows that of the well-known and internationally recognized Braunwald’s Heart Disease.
• Review the best available clinical data and pragmatic recommendations for the prevention and management of cardiovascular complications of diabetes; national/societal intervention strategies to curb the growing prevalence of diabetes; and the current pathophysiological understanding of cardiovascular comorbidities in patients with diabetes.
• Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability.

Diabetes in Cardiovascular Disease is a current, expert resource focusing on the complex challenges of providing cardiovascular care to patients with diabetes. Designed as a companion to Braunwald's Heart Disease , this interdisciplinary medical reference book bridges the gap between the cardiology and endocrinology communities of scientists and care providers, and highlights the emerging scientific and clinical topics that are relevant for cardiologists, diabetologists/endocrinologists, and the extended diabetes care team. Access essential coverage of basic and clinical sciences , complemented by an expanded focus on epidemiology, behavioral sciences, health policy, and disparities in health care. Take advantage of a format that follows that of the well-known and internationally recognized Braunwald's Heart Disease. Review the best available clinical data and pragmatic recommendations for the prevention and management of cardiovascular complications of diabetes; national/societal intervention strategies to curb the growing prevalence of diabetes; and the current pathophysiological understanding of cardiovascular comorbidities in patients with diabetes. Consult this title on your favorite e-reader , conduct rapid searches, and adjust font sizes for optimal readability. "As the magnitude of cardiovascular diseases (CVDs) continue to accelerate globally, the pressing need for increased awareness and for stronger and more focused international and country responses is increasingly recognized. This atlas on cardiovascular disease prevention and control is part of the response to this need. It documents the magnitude of the problem, using global cardiovascular mortality and morbidity data. It demonstrates the inequities in access to protection, exposure to risk, and access to care as the cause of major inequalities between countries and populations in the occurrence and outcome of CVDs. The report has graphs showing mortality rates of CVDs by age, by country/region, and is divided into three main sections: Section A: Cardiovascular diseases due to atherosclerosis -- Section B: Other cardiovascular diseases -- Section C: Prevention and control of CVDs: Policies, strategies and interventions."--Provided by publisher The Global Status Report on Noncommunicable Diseases is the first. report on the worldwide epidemic of cardiovascular diseases cancer. diabetes and chronic respiratory diseases along with their risk factors. and determinants. Noncommunicable diseases killed 36 million people. in 2008 and a large proportion of these deaths occurred before the age. of 60 so during the most productive period of life. The magnitude of. these diseases continues to rise especially in low- and middle-income. countries. This report reviews the current status of noncommunicable. diseases and provides a roadmap for reve "Global status report on noncommunicable diseases is the first report on the worldwide epidemic of cardiovascular diseases, cancer, diabetes and chronic respiratory diseases, along with their risk factors and determinants."--Back cover